Salute e Benessere

Novogene Expands UK Offerings with Launch of ONT-Based Whole Plasmid Sequencing…

Novogene's Whole Plasmid Sequencing service provides full coverage for plasmids up to tens of kilobases in length, ensuring complete and accurate characterisation. With a streamlined workflow, researchers can benefit from next-day turnaround and high-quality, long-read data. Novogene's Whole Plasmid Sequencing service provides full coverage for plasmids up to tens of kilobases in length, ensuring complete and accurate characterisation. With a streamlined workflow, researchers can benefit from...
PR Newswire
05/11/2025

Oculis to Participate in Upcoming November Investor Conferences

/ XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, announced today that Oculis’ management will participate in upcoming investor conferences in November.Oculis is pleased to present updates of its innovative, highly differentiated, late-stage portfolio as it enters a pivotal phase in its transformation into a leader in neuro-ophthalmology and ophthalmology...
Nasdaq GlobeNewswire
05/11/2025

Natural Field will Launch "Ashwagandha White Paper" at FTA Forum in Hangzhou

The Ashwagandha White Paper compiles years of research, including analytical data, quality evaluation protocols, and practical applications in functional formulations. By providing clear scientific insights and standardized references, it serves as a critical resource for R&D teams, product developers, and brand innovators worldwide seeking premium botanical ingredients. TheAshwagandha White Papercompiles years of research, including analytical data, quality evaluation protocols, and...
PR Newswire
05/11/2025

Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for…

"We are very pleased to enter this partnership with Karo Healthcare, which has a strong commercial presence across Europe. Launching MOB-015/Terclara® under the well-known Lamisil® brand gives us an exceptional opportunity to establish the product as the market leader also beyond Sweden and Norway," says Anna Ljung, CEO of Moberg Pharma. "We are very pleased to enter this partnership with Karo Healthcare, which has a strong commercial presence acrossEurope. Launching…
PR Newswire
05/11/2025

Top-rated Canadian healthcare provider adopts Sectra's enterprise imaging as a…

"As Sectra will take full responsibility for the system's technology, it will ease the burden on our IT team. We also hope to enhance diagnostic speed for our physicians as this transition will provide them with tools for increased efficiency and improved collaboration capabilities. We are happy to begin implementing Sectra's cloud solution and are looking forward to experiencing the benefits it will bring for our organization and staff," says Amir Soheili, Vice President, Digital…
PR Newswire
05/11/2025

Karo Healthcare enters an exclusive license agreement with Moberg Pharma for…

The agreement further strengthens our position in the foot health category, one of Karo's core focus areas, where we already have established brands and deep expertise across commercial execution, consumer insights, and regulatory know-how. The agreement further strengthens our position in the foot health category, one of Karo's core focus areas, where we already have established brands and deep expertise across commercial execution, consumer insights, and regulatory know-how. MOB-015,...
PR Newswire
05/11/2025

ACTO UNVEILS ACTOVERSE: A PARTNER SOLUTIONS MARKETPLACE DRIVING INNOVATION AND…

ACTOverse simplifies how biopharmaceutical and medical device companies discover, evaluate, and deploy complementary content, data, and services that enhance field training and enablement. ACTOverse partner solutions are pre-vetted by ACTO and built to work seamlessly with the ACTO platform for turnkey implementation and faster time-to-value. ACTOverse simplifies how biopharmaceutical and medical device companies discover, evaluate, and deploy complementary content, data, and services that...
PR Newswire
05/11/2025

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

COPENHAGEN, Denmark, November 5, 2025– Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 4.92% of the shares and voting rights in Bavarian Nordic A/S as of October 30, 2025.About Bavarian NordicBavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox...
Nasdaq GlobeNewswire
05/11/2025

TME Pharma advances its new investment strategy and signs LOI with German…

TME Pharma advances its new investment strategy and signs LOI with German resources companyA further step toward investment diversification into potential cash-flow–generating assets A potential strategic investment in sustainable tailings reprocessing and environmental rehabilitation projects for precious metals with strong value-creation prospects. Upon successful completion of due diligence, the proposed transaction will be submitted to shareholders at an Extraordinary...
Nasdaq GlobeNewswire
05/11/2025

Novo Nordisk's sales increased by 12% in Danish kroner and by 15% at CER in the…

Bagsværd, 5 November, 2025 - Financial report for the period 1 January 2025 to 30 September 2025 Operating profit increased by 5% in Danish kroner and 10% at constant exchange rates (CER) to DKK 95.9 billion, impacted by one-off restructuring costs of around DKK 9 billion related to the company-wide transformation with the aim of streamlining Novo Nordisk's operations to...
Nasdaq GlobeNewswire
05/11/2025

Santhera Closes USD 13 Million Royalty Monetization Agreement

Pratteln, Switzerland, November 5, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the closing of a USD 13 million royalty monetization agreement, first announced in September 2025, to support the global launches of AGAMREE® (vamorolone). The agreement was initially secured in September 2025 with R-Bridge, an affiliate of CBC Group, covering 25% of net royalties on AGAMREE from Catalyst Pharmaceuticals, Inc. in North America and Sperogenix Therapeutics Ltd in China. Since initially...
Nasdaq GlobeNewswire
05/11/2025

Tinnitus UK Rates Lenire as Most Effective Treatment Option

"Neuromod welcomes Tinnitus UK's decision to recognise Lenire, and bimodal neuromodulation, as a safe and effective standard of care for tinnitus treatment," said Neuromod founding CEO, Dr. Ross O'Neill. "Millions of people in the UK and across Europe rely on Tinnitus UK for advice about treatment options and we are delighted that Neurmod's commitment to building compelling evidence is reflected in this new rating for Lenire." "Neuromod welcomes Tinnitus UK's decision to…
PR Newswire
05/11/2025

Mölnlycke® establishes first wound care manufacturing site in China

The manufacturing site, spanning 10,000 m2, will be set up in accordance with Mölnlycke's global standards and is expected to initiate production of Mölnlycke wound care products at the end of 2026/early 2027. This strategic move will help future-proof Mölnlycke's growth in China, laying the foundation for future capacity expansion and local job creation. The manufacturing site, spanning10,000 m2, will be set up in accordance with Mölnlycke's global standards and is expected to initiate...
PR Newswire
05/11/2025

Cholestatic Pruritus Market is Predicted to Exhibit Remarkable Growth at a CAGR…

Cholestatic Pruritus Market Summary Cholestatic Pruritus Market Summary Discover the cholestatic pruritus new treatment @New Treatments for Cholestatic Pruritus Key Factors Driving the Growth of the Cholestatic Pruritus Market PBC as the Leading Contributor to Disease Burden Cholestatic pruritus posed a significant clinical burden across rare liver diseases in the US in 2024, with approximately 76K cases in PBC, followed by PSC, ALGS, biliary atresia, and PFIC...
PR Newswire
04/11/2025

DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare…

DBV Technologies to Participate in the Guggenheim 2 ndAnnual Healthcare Innovation Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today announced Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the Guggenheim 2 ndAnnual Healthcare Innovation Conference on Tuesday, November 11, at 2:00 p.m. ET in Boston, Massachusetts.A live webcast of the...
Nasdaq GlobeNewswire
04/11/2025

Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for…

REYKJAVIK, ICELAND (November 4, 2025)– Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first nine months of the year ended September 30, 2025, after U.S. markets close on Wednesday, November 12, 2025. Alvotech will also conduct a conference call to present the financial results on Thursday November 13, 2025, at 8:00 am EST (13:00...
Nasdaq GlobeNewswire
04/11/2025

INTREPID Alliance Launches Antiviral Toolbox to Support Global Research…

Small-molecule antivirals are indispensable tools for rapid, scalable, and equitable responses to epidemic and pandemic threats.1 INTREPID's latest review of the global antiviral R&D landscape reveals that beyond Coronaviridae, only 27 antiviral compounds are in clinical development to tackle 12 viral families and their multiple diseases of greatest pandemic concern. Furthermore, there are no clinical development efforts underway for 4 viral families of pandemic potential (Paramyxoviridae…
PR Newswire
04/11/2025

Healthcare Analytics Market Size to grow USD 532.75 Billion by 2035, at 25.75%…

Healthcare analytics encompassing descriptive, predictive, and prescriptive tools—has evolved into a core pillar of executive decision-making, allowing leaders to convert massive healthcare data sets into actionable intelligence. Through AI, cloud computing, and real-time analytics, the industry is achieving unprecedented progress in personalized care, cost efficiency, and data transparency. Healthcare analytics encompassing descriptive, predictive, and prescriptive tools—has evolved into a...
PR Newswire
04/11/2025

DMS GROUP RECEIVES FDA CLEARANCE FOR ITS !M1 MOBILE RADIOLOGY SYSTEM AS PART OF…

A new strategic milestone in DMS Group's expansion in North America ahead of RSNA 2025 November 4, 2025 – 5:45 pm – Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 – ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry, announces that its !M1 mobile radiology system has…
Actusnews Wire
04/11/2025

Point-of-Care Molecular Diagnostics Market Surges to USD 15.2 Billion by 2033…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=819568 Download PDF Brochure:https://www.verifiedmarketreports.com/download-sample/?rid=819568 Browse in-depth TOC on Point-of-Care Molecular Diagnostics Market 202 - Pages 126 – Tables 37 – Figures Scope of The Point-of-Care Molecular Diagnostics Market Report Global Point-of-Care Molecular Diagnostics Market Overview Point-of-Care Molecular Diagnostics Market: Trends and...
PR Newswire
04/11/2025

Drill Surgical Power Tool Market Amid Rising Surgical Demand and Advancing…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=285778 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=285778 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Drill Surgical Power Tool Market Overview 1. Rising Demand for Orthopedic and Trauma Surgeries The Drill Surgical Power Tool Market is strongly supported by the growing global incidence of orthopedic disorders, trauma...
PR Newswire
04/11/2025

Bariatric Beds Market to Reach $583.8 million, Globally, by 2034 at 5.3% CAGR…

Request Sample of the Report on Bariatric Beds Market Forecast 2034 - https://www.alliedmarketresearch.com/request-sample/A62724 Request Sample of the Report on Bariatric Beds Market Forecast 2034 -https://www.alliedmarketresearch.com/request-sample/A62724 Market Introduction Bariatric beds comprise specialized hospital and homecare beds designed to accommodate patients with obesity or morbid obesity, typically supporting weights above standard hospital bed limits. These beds...
PR Newswire
04/11/2025

Blood Collection Devices Market worth $13.02 billion by 2030 with 7.4% CAGR |…

Browse in-depth TOC on "Blood Collection Devices Market" Browse in-depth TOC on "Blood Collection Devices Market" 374 - Tables50 - Figures321 - Pages By product,the global blood collection devices market is segmented into blood collection tubes, needles & syringes, blood collection systems/monitors, blood bags, and lancets. In 2024, the blood collection tubes segment accounted for the largest share of the blood collection devices market. The strong position of this...
PR Newswire
04/11/2025

Global AI-Powered Pathology Market Valued at USD 184 Million in 2023, Set to…

The global AI-Powered Pathology Market is projected to grow significantly in the coming years. It was valued at USD 184 Million in 2023 and is forecast to reach USD 382 Million by 2030, representing a robust compound annual growth rate (CAGR) of 11.7% during 2024–2030. The global AI-Powered Pathology Market is projected to grow significantly in the coming years. It was valued atUSD 184 Millionin 2023 and is forecast to reachUSD 382 Millionby 2030, representing a robust compound annual...
PR Newswire
04/11/2025
Altri  Comunicati